SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-22-022223
Filing Date
2022-02-14
Accepted
2022-02-14 12:37:36
Documents
2
Group Members
BRIAN D. GROSSMANPARTNER ASSET MANAGEMENT, LLCPFM HEALTH SCIENCES GP, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13G/A tm225765d2_sc13ga.htm SC 13G/A 108937
2 JOINT FILING AGREEMENT tm225765d2_ex99-1.htm EX-99.1 6549
  Complete submission text file 0001104659-22-022223.txt   117219
Mailing Address 475 SANSOME STREET SUITE 1720 SAN FRANCISCO CA 94111
Business Address 475 SANSOME STREET SUITE 1720 SAN FRANCISCO CA 94111 415-281-1022
PFM Health Sciences, LP (Filed by) CIK: 0001442756 (see all company filings)

IRS No.: 262000428 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139 857-259-3840
Jounce Therapeutics, Inc. (Subject) CIK: 0001640455 (see all company filings)

IRS No.: 454870634 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-89831 | Film No.: 22628193
SIC: 2836 Biological Products, (No Diagnostic Substances)